Cargando…

Cenobamate (YKP3089) as adjunctive treatment for uncontrolled focal seizures in a large, phase 3, multicenter, open‐label safety study

OBJECTIVE: During the development of cenobamate, an antiseizure medication (ASM) for focal seizures, three cases of drug reaction with eosinophilia and systemic symptoms (DRESS) occurred. To mitigate the rate of DRESS, a start‐low, go‐slow approach was studied in an ongoing, open‐label, multicenter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sperling, Michael R., Klein, Pavel, Aboumatar, Sami, Gelfand, Michael, Halford, Jonathan J., Krauss, Gregory L., Rosenfeld, William E., Vossler, David G., Wechsler, Robert, Borchert, Leona, Kamin, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Full‐length Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317552/ https://www.ncbi.nlm.nih.gov/pubmed/32396252 http://dx.doi.org/10.1111/epi.16525

Ejemplares similares

Suppression of the photoparoxysmal response in photosensitive epilepsy with cenobamate (YKP3089)
por: Kasteleijn- Nolst Trenite, Dorothee G.A., et al.
Publicado: (2019)

Cenobamate (YKP3089) and Drug-Resistant Epilepsy: A Review of the Literature
por: Rissardo, Jamir Pitton, et al.
Publicado: (2023)

Efficacy of cenobamate for uncontrolled focal seizures: Post hoc analysis of a Phase 3, multicenter, open‐label study
por: Sperling, Michael R., et al.
Publicado: (2021)

Post hoc analysis of a phase 3, multicenter, open‐label study of cenobamate for treatment of uncontrolled focal seizures: Effects of dose adjustments of concomitant antiseizure medications
por: Rosenfeld, William E., et al.
Publicado: (2021)

Long‐term safety of adjunctive cenobamate in patients with uncontrolled focal seizures: Open‐label extension of a randomized clinical study
por: French, Jacqueline A., et al.
Publicado: (2021)

Randomized phase 2 study of adjunctive cenobamate in patients with uncontrolled focal seizures
por: Chung, Steve S., et al.
Publicado: (2020)

Long-term Efficacy and Safety From an Open-Label Extension of Adjunctive Cenobamate in Patients With Uncontrolled Focal Seizures
por: Klein, Pavel, et al.
Publicado: (2022)

Critical Appraisal of Cenobamate as Adjunctive Treatment of Focal Seizures in Adults
por: Zaccara, Gaetano, et al.
Publicado: (2021)

Adjunctive Cenobamate for Focal-Onset Seizures in Adults: A Systematic Review and Meta-Analysis
por: Lattanzi, Simona, et al.
Publicado: (2020)

Remarkably High Efficacy of Cenobamate in Adults With Focal-Onset Seizures: A Double-Blind, Randomized, Placebo-Controlled Trial
por: Vossler, David G.
Publicado: (2020)

Long‐term individual retention with cenobamate in adults with focal seizures: Pooled data from the clinical development program
por: Sander, Josemir W., et al.
Publicado: (2021)

Effectiveness and safety of adjunctive cenobamate for focal seizures in adults with developmental disability treated in clinical practice
por: Connor, Gregory S., et al.
Publicado: (2022)

Cenobamate for treatment-resistant focal seizures: current evidence and place in therapy
por: Singh, Alok
Publicado: (2022)

Dose Adjustment of Concomitant Antiseizure Medications During Cenobamate Treatment: Expert Opinion Consensus Recommendations
por: Smith, Michael C., et al.
Publicado: (2022)

Effect of HO-3089 PARP inhibitor on inflammatory response
por: Nemeth, M, et al.
Publicado: (2011)

Eslicarbazepine acetate as adjunctive therapy in patients with uncontrolled partial-onset seizures: Results of a phase III, double-blind, randomized, placebo-controlled trial
por: Sperling, Michael R, et al.
Publicado: (2015)

Onset of efficacy and adverse events during Cenobamate titration period
por: Steinhoff, Bernhard J., et al.
Publicado: (2022)

Perampanel in real‐world clinical care of patients with epilepsy: Interim analysis of a phase IV study
por: Wheless, James, et al.
Publicado: (2020)

Complete Genome Sequence of an Oral Commensal, Streptococcus oligofermentans Strain AS 1.3089
por: Tong, Huichun, et al.
Publicado: (2013)

Real‐world safety and effectiveness of cenobamate in patients with focal onset seizures: Outcomes from an Expanded Access Program
por: Villanueva, Vicente, et al.
Publicado: (2023)

Is Cenobamate the Breakthrough We Have Been Wishing for?
por: Specchio, Nicola, et al.
Publicado: (2021)

Assessment of the long‐term efficacy and safety of adjunctive perampanel in tonic‐clonic seizures: Analysis of four open‐label extension studies
por: Rektor, Ivan, et al.
Publicado: (2020)

Cost-effectiveness of perampanel as an adjunctive treatment for uncontrolled focal seizures in pediatric patients: a Chinese perspective
por: Hu, Yani, et al.
Publicado: (2022)

Efficacy and safety of conversion to monotherapy with eslicarbazepine acetate in adults with uncontrolled partial‐onset seizures: A randomized historical‐control phase III study based in North America
por: Sperling, Michael R., et al.
Publicado: (2015)

Effect of Regular Exercise on Inflammation Induced by Drug-resistant Staphylococcus aureus 3089 in ICR mice
por: Lee, Jong-Kook, et al.
Publicado: (2015)

An Ex Vivo Evaluation of Cenobamate Administered via Enteral Tubes
por: Ferrari, Louis, et al.
Publicado: (2020)

Real-World Experience Treating Pediatric Epilepsy Patients With Cenobamate
por: Makridis, Konstantin L., et al.
Publicado: (2022)

Cenobamate in refractory epilepsy: Overview of treatment options and practical considerations
por: Schmitz, Bettina, et al.
Publicado: (2023)

Effect of cenobamate on the single‐dose pharmacokinetics of multiple cytochrome P450 probes using a cocktail approach in healthy subjects
por: Greene, Stephen A., et al.
Publicado: (2021)

Anticonvulsant effects of cenobamate in chemically and electrically induced seizure models in rodents
por: Melnick, Susan M., et al.
Publicado: (2023)

Incidence, prevalence, and national burden of interstitial lung diseases in India: Estimates from two studies of 3089 subjects
por: Dhooria, Sahajal, et al.
Publicado: (2022)

Recombinant activated factor VII for uncontrolled bleeding postcardiac surgery
por: Habib, Aly Makram, et al.
Publicado: (2016)

Serum sodium levels and related treatment‐emergent adverse events during eslicarbazepine acetate use in adults with epilepsy
por: Wechsler, Robert T., et al.
Publicado: (2019)

Sensitivity and responsiveness of the EQ-5D-3L in patients with uncontrolled focal seizures: an analysis of Phase III trials of adjunctive brivaracetam
por: Mukuria, Clara, et al.
Publicado: (2016)

The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and Beyond
por: Löscher, Wolfgang, et al.
Publicado: (2021)

Treatment with Cenobamate in Adult Patients with Lennox–Gastaut Syndrome: A Case Series
por: Falcicchio, Giovanni, et al.
Publicado: (2022)

Conversion to lacosamide monotherapy in the treatment of focal epilepsy: Results from a historical-controlled, multicenter, double-blind study
por: Wechsler, Robert T, et al.
Publicado: (2014)

3089 Clinicopathologic and Prognostic Significance of LGR5, a Cancer Stem cell Marker in Peritoneal Metastasis of a Colorectal Origin
por: Ihemelandu, Chukwuemeka
Publicado: (2019)

Open‐label study to investigate the safety and efficacy of adjunctive perampanel in pediatric patients (4 to <12 years) with inadequately controlled focal seizures or generalized tonic‐clonic seizures
por: Fogarasi, Andras, et al.
Publicado: (2020)

Clinical utility of implantable neurostimulation devices as adjunctive treatment of uncontrolled seizures
por: Cox, Joanna H, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ra59lmttm56hmskjnav1ift88j